Third Eye Diagnostics is a medical device company developing diagnostic tools using ophthalmic technologies. Addressing the unmet need for non-invasively diagnosing elevated intracranial pressure the firm's developed device is a non-invasive intracranial pressure monitor that is designed to be used by physicians in the diagnosis and treatment of head injury. Patients with head injury, hemorrhage, or stroke require monitoring of intracranial pressure. Withe NSF SBIR support, the firm undertook the prototype development and clinical studies that preceded commercialization of their device - designated Cerepress, a non-invasive intracranial pressure (ICP) monitor. The monitor gathers pressure measurements externally from the eye of patients with a head injury or who have suffered a stroke. Existing standard-of-care devices that monitor ICP are invasive and require drilling a hole through the patientâs skull to measure pressure potentially exposing patients to significant complications, and posing a significant and preventable cost. Third Eye's product represented a first-of-its-kind non-invasive intracranial pressure monitor gathering information from the patient's eye. The technology was based on one issued patent, one pending patent, and two applications in progress atthe timeof award on methods and apparatus that correlate ICP with measurements taken from the blood vessels within the eye. The Cerepress⢠measures blood pressure in the eyeâs central retinal vein (CRV) which highly correlates to intracranial pressure. 2019: Present status of firm and the project is not c